NINDS Seeks Validated Targets for Huntington's Disease | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute for Neurological Disorders and Stroke will grant up to $4.5 million in 2011 to support research projects that will validate novel molecular targets for disease-modifying therapeutic intervention in Huntington's disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.